Ion channels and apoptosis in cancer

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 369, Issue 1638, 2014, Pages

  Bortner, Carl D ^a   Cidlowski, John A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Apoptosis; Cancer; Cell death; Ion channels

Indexed keywords

ABNORMALITY; APOPTOSIS; CANCER; CYTOLOGY; DISEASE TREATMENT; HOMINID; ION; PATHOLOGY; PHYSIOLOGY;

ION CHANNEL;

APOPTOSIS; BIOLOGICAL MODEL; CELL DEATH; HUMAN; METABOLISM; NECROSIS; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; CANCER; CELL DEATH; ION CHANNELS;

APOPTOSIS; CELL DEATH; HUMANS; ION CHANNELS; MODELS, BIOLOGICAL; NECROSIS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84893443692     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2013.0104     Document Type: Review

References (120)

1. Krysko DV, Vanden Berghe T, D'Herde K, Vandenabeele P. 2008 Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods 44, 205-221. (doi:10.1016/j.ymeth. 2007.12.001)
2. McConkey DJ. 1998 Biochemical determinants of apoptosis and necrosis. Toxicol. Lett. 99, 157-168. (doi:10.1016/S0378-4274(98)00155-6)
3. Kerr JFR, Wyllie AH, Currie AR. 1972 Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257. (doi:10.1038/bjc.1972.33)
4. Kerr JFR. 1965 A histochemical study of hypertrophy and ischaemic injury of rat liver with special reference to changes in lysosomes. J. Pathol. Bacteriol. 90, 419-435. (doi:10.1002/path. 1700900210)
5. Kerr JFR. 1971 Shrinkage necrosis: a distinct mode of cellular death. J. Pathol. 105, 13-20. (doi:10.1002/path.1711050103)
6. Wyllie AH, Kerr JFR, Currie AR. 1973 Cell death in the normal neonatal rat adrenal cortex. J. Pathol. 111, 255-261. (doi:10.1002/path.1711110406)
7. Kerr JFR, Searle J. 1972 A suggested explanation for the paradoxically slow growth rate of basal-cell carcinomas that contain numerous mitotic figures. J. Pathol. 107, 41-44. (doi:10.1002/path. 1711070107)
8. Wyllie AH, Kerr JFR, Macaskill IA, Currie AR. 1973 Adrenocortical cell deletion: the role of ACTH. J. Pathol. 111, 85-94. (doi:10.1002/path. 1711110203)
9. Schwartzman RA, Cidlowski JA. 1993 Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr. Rev. 14, 133-151.
10. Chowdhury I, Tharaken B, Bhat GK. 2006 Current concepts in apoptosis: the physiological suicide program revisited. Cell. Mol. Biol. Lett. 11, 506-525. (doi:10.2478/s11658-006-0041-3)
11. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FK. 2009 Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112-1123. (doi:10.1016/j. cell.2009.05.037)
12. He S, Wang L, Miao L, Wang T, Du F, Zhao L, Wang X. 2009 Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α. Cell 137, 1100-1111. (doi:10.1016/j.cell.2009. 05.021)
13. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, Yuan J. 2008 Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135, 1311-1323. (doi:10.1016/j.cell.2008.10.044)
14. Vandenabeele P, Galluzzi L, Vander Berghe T, Kroemer G. 2010 Molecular mechanisms of necrotosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11, 700-714. (doi:10.1038/nrm2970)
15. Weerasinghe P, Buja LM. 2012 Oncosis: an important non-apoptotic mode of cell death. Exp. Mol. Pathol. 93, 302-308. (doi:10.1016/j.yexmp. 2012.09.018)
16. Franchi L, Muñoz-Planillo R, Núñez G. 2012 Sensing and reacting to microbes through the inflammasomes. Nat. Immunol. 13, 325-332. (doi:10.1038/ni.2231)
17. Kraft C, Reggiori F, Peter M. 2009 Selective types of autophagy in yeast. Biochim. Biophys. Acta 1793, 1404-1412. (doi:10.1016/j.bbamcr.2009.02.006)
18. Mukaiyama H, Nakase M, Nalamura T, Kakinuma Y, Takegawa K. 2010 Autophagy in the fission yeast Schizosaccharomyces pombe. FEBS Lett. 584, 1327-1334. (doi:10.1016/j.febslet.2009.12.037)
19. Son JH, Shim JH, Kim KH, Ha JY, Han JY. 2012 Neuronal autophagy and neurodegenerative diseases. Exp. Mol. Med. 44, 89-98. (doi:10.3858/emm.2012.44.2.031)
20. Harris H, Rubinsztein DC. 2011 Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 8, 108-117. (doi:10.1038/nrneurol. 2011.200)
21. Guicciardi ME, Gores GJ. 2009 Life and death by death receptors. FASEB J. 23, 1625-1637. (doi:10.1096/fj.08-111005)
22. Lavrik IN, Krammer PH. 2012 Regulation of CD95/Fas signaling at the DISC. Cell Death Differ. 19, 36-41. (doi:10.1038/cdd.2011.155)
23. Oberst A, Bender C, Green DR. 2008 Living with death: the evolution of the mitochondrial pathway of apoptosis in animals. Cell Death Differ. 15, 1139-1146. (doi:10.1038/cdd.2008.65)
24. Riedl SJ, Salvesen GS. 2007 The apoptosome: signaling platform of cell death. Nat. Rev. Mol. Cell Biol. 8, 305-413.
25. Bao Q, Shi Y. 2007 Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ. 14, 56-65. (doi:10.1038/sj.cdd.4402028)
26. Li H, Zhu H, Xu CJ, Yuan J. 1998 Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501. (doi:10.1016/S0092-8674(00)81590-1)
27. Yin XM, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B, Roth KA, Korsmeyer SJ. 1999 Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400, 886-891. (doi:10.1038/23730)
28. Bortner CD, Cidlowski JA. 2002 Cellular mechanisms for the repression of apoptosis. Annu. Rev. Pharmocol. Toxicol. 42, 259-281. (doi:10.1146/annurev.pharmtox.42.083101.143836)
29. Crook NE, Clem RJ, Miller LK. 1993 An apoptosisinhibiting baculovirus gene with a zinc finger-like motif. J. Virol. 67, 2168-2174.
30. Birnbaum MJ, Clem RJ, Miller LK. 1994 An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a poly-peptide with Cys/His sequence motifs. J. Virol. 68, 2521-2528.
31. Deveraux QL, Reed JC. 1999 IAP family proteinssuppressors of apoptosis. Genes Dev. 13, 239-252. (doi:10.1101/gad.13.3.239)
32. Antonsson B, Martinou JC. 2000 The Bcl-2 protein family. Exp. Cell Res. 256, 50-57. (doi:10.1006/excr.2000.4839)
33. Lindsay J, Esposti MD, Gilmore AP. 2011 Bcl-2 protein and mitochondria: specificity in membrane targeting for death. Biochem. Biophys. Acta 1813, 532-539. (doi:10.1016/j. bbamcr.2010.10.017)
34. + inhibit cytochrome c-dependent formation of the apoptosome. J. Biol. Chem. 276, 41 985-41 990. (doi:10.1074/jbc.M107419200)
35. +] inhibits deathreceptor and chemical-mediated apoptosis prior to caspase activation and cytochrome c release. Biochem. J. 357, 137-145. (doi:10.1042/0264-6021:3570137)
36. Bortner CD, Cidlowski JA. 2011 Life and death of lymphocytes: a volume regulation affair. Cell. Physiol. Biochem. 28, 1079-1088. (doi:10.1159/000335864)
37. Bortner CD, Cidlowski JA. 2007 Cell shrinkage and monovalent cation fluxes: role in apoptosis. Arch. Biochem. Biophys. 462, 176-188. (doi:10.1016/j. abb.2007.01.020)
38. Lang F, Foller M, Lang K, Lang P, Ritter M, Vereninov A, Szabo I, Huber SM, Gulbins E. 2007 Cell volume regulatory ion channels in cell proliferation and cell death. Methods Enzymol. 428, 209-225. (doi:10.1016/S0076-6879(07)28011-5)
39. Maeno E, Ishizaki Y, Kanaseki T, Hazama A, Okada Y. 2000 Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc. Natl Acad. Sci. USA 97, 9487-9492. (doi:10.1073/pnas.140216197)
40. + efflux in the activation of apoptosis. J. Biol. Chem. 272, 32 436-32 442. (doi:10.1074/jbc.272.1.32)
41. + suppresses the activation of apoptosis in lymphocytes. J. Biol. Chem. 272, 30 567-30 576. (doi:10.1074/jbc.272.48.30567)
42. Lang F, Foller M, Lang KS, Lang PA, Ritter M, Gulbins E, Vereninov A, Huber SM. 2005 Ion channels in cell proliferation and apoptotic cell death. J. Membr. Biol. 205, 147-157. (doi:10.1007/s00232-005-0780-5)
43. Heimlich G, Bortner CD, Cidlowski JA. 2004 Apoptosis and cell volume regulation: the importance of ions and ion channels. Adv. Exp. Med. Biol. 559, 189-203.
44. Gantner F, Uhlig S, Wendel A. 1995 Quinine inhibits release of tumor necrosis factor, apoptosis, necrosis and mortality in a murine model of septic liver failure. Eur. J. Pharmacol. 294, 353-355. (doi:10.1016/0014-2999(95)00724-5)
45. Wang X, Xiao AY, Ichinose T, Yu SP. 2000 Effects of tetraethylammonium analogs on apoptosis and membrane currents in cultured cortical neurons. J. Pharmacol. Exp. Ther. 295, 524-530.
46. Franco R, Bortner CD, Cidlowski JA. 2006 Potential roles of electrogenic ion transport and plasma membrane depolarization in apoptosis. J. Membr. Biol. 209, 43-58. (doi:10.1007/s00232-005-0837-5)
47. Bortner CD, Sifre MI, Cidlowski JA. 2008 Cationic gradient reversal and cytoskeleton-independent volume regulatory pathways define an early stage of apoptosis. J. Biol. Chem. 283, 7219-7229. (doi:10.1074/jbc.M707809200)
48. + influx is required for volume loss during programmed cell death. J. Biol. Chem. 278, 39 176-39 184. (doi:10.1074/jbc.M303516200)
49. Yurinskaya VA et al. 2005 Potassium and sodium balance in U937 cells during apoptosis with and without cell shrinkage. Cell. Physiol. Biochem. 16, 155-162. (doi:10.1159/000089841)
50. Okada Y, Maeno E, Shimizu T, Manabe K, Mori S, Nabekura T. 2004 Dual roles of plasmalemmal chloride channels in induction of cell death. Pflugers Arch. 448, 287-295. (doi:10.1007/s00424-004-1276-3)
51. Heimlich G, Cidlowski JA. 2006 Selective role of intracellular chloride in the regulation of the intrinsic but not extrinsic pathway of apoptosis in Jurkat T-cells. J. Biol. Chem. 281, 2232-2241. (doi:10.1074/jbc.M507367200)
52. Okada Y, Shimizu T, Maeno E, Tanabe S, Wang X, Takahashi N. 2006 Volume-sensitive chloride channels involved in apoptotic volume decrease and cell death. J. Membr. Biol. 209, 21-29. (doi:10.1007/s00232-005-0836-6)
53. Wang X, Takahashi N, Uramoto H, Okada Y. 2005 Chloride channel inhibition prevents ROS-dependent apoptosis induced by ischemia-reperfusion in mouse cardiomyocytes. Cell. Physiol. Biochem. 16, 147-154. (doi:10.1159/000089840)
54. Hoffmann EK, Lambert IH, Pedersen SF. 2009 Physiology of cell volume regulation in vertebrates. Physiol. Rev. 89, 193-277. (doi:10.1152/physrev. 00037.2007)
55. Dubis JM, Rouzaire-Dubois B. 2012 Roles of cell volume in molecular and cellular biology. Prog. Biophys. Mol. Biol. 108, 93-97. (doi:10.1016/j. pbiomolbio.2011.12.001)
56. Lambert IH, Hoffman EK, Pedersen SF. 2008 Cell volume regulation: physiology and pathophysiology. Acta Physiol. 194, 255-282. (doi:10.1111/j.1748-1716.2008.01910.x)
57. Bortner CD, Cidlowski JA. 1996 Absence of volume regulatory mechanisms contributes to the rapid activation of apoptosis in thymocytes. Am. J. Physiol. Cell Physiol. 271, C950-C961.
58. Shimizu T, Wehner F, Okada Y. 2006 Inhibition of hypertonicity-induced cation channels sensitizes HeLa cells to shrinkage-induced apoptosis. Cell. Physiol. Biochem. 18, 295-302. (doi:10.1159/000097607)
59. Simpson CD, Anyiwe K, Schimmer AD. 2008 Anoikis resistance and tumor metastasis. Cancer Lett. 272, 177-185. (doi:10.1016/j.canlet. 2008.05.029)
60. Sayers TJ. 2011 Targeting the extrinsic apoptosis signaling pathway for cancer therapy. Cancer Immunol. Immunother. 60, 1173-1180. (doi:10.1007/s00262-011-1008-4)
61. Ashkenazi A et al. 1999 Sagety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104, 155-162. (doi:10.1172/JCI6926)
62. Kelley SK, Ashkenazi A. 2004 Targeting death receptors in cancer with Apo2L/TRAIL. Curr. Opin. Pharmacol. 4, 333-339. (doi:10.1016/j.coph. 2004.02.006)
63. Ashkenazi A. 2002 Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat. Rev. Cancer 2, 420-430. (doi:10.1038/nrc821)
64. Jendrossek V. 2012 The intrinsic apoptosis pathways as a target in anticancer therapy. Curr. Pharm. Biotechnol. 13, 1426-1438. (doi:10.2174/138920112800784989)
65. Kang MH, Reynolds CP. 2009 Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin. Cancer Res. 15, 1126-1132. (doi:10.1158/1078-0432.CCR-08-0144)
66. Gjertsen BT, Bredholt T, Anensen N, Vintermyr OK. 2007 Bcl-2 antisense in the treatment of human malignancies: a delusion in targeted therapy. Curr. Pharm. Biotechnol. 8, 373-381. (doi:10.2174/138920107783018381)
67. Chonghaile TN, Letai A. 2008 Mimicking the BH3 domain to kill cancer cells. Oncogene 27, S149-S157. (doi:10.1038/onc.2009.52)
68. Azmi AS, Mohammad RM. 2009 Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy. J. Cell Physiol. 218, 13-21. (doi:10.1002/jcp.21567)
69. Prevarskaya N, Skryma R, Shuba Y. 2010 Ion channels and the hallmarks of cancer. Trends Mol. Med. 16, 107-121. (doi:10.1016/j.molmed.2010. 01.005)
70. Hanahan D, Weinberg RA. 2000 The hallmarks of cancer. Cell 100, 57-70. (doi:10.1016/S0092-8674(00)81683-9)
71. Lang F, Shumilina E, Ritter M, Gulbins E, Vereninov A, Huber SM. 2006 Ion channels and cell volume in regulation of cell proliferation and apoptotic cell death. Contrib. Nephrol. 152, 142-160.
72. + channels support proliferation of colonic carcinoma cells. FASEB J. 21, 35-44. (doi:10.1096/fj.06-6200com)
73. Repp H, Draheim H, Ruland J, Seidel G, Beise J, Presek P, Dreyer F. 1993 Profound differences in potassium current properties of normal and Rous scrcoma virus-transformed chicken embryo fibloblasts. Proc. Natl Acad. Sci. USA 90, 3403-3407. (doi:10.1073/pnas.90.8.3403)
74. + channel blockers. J. Cell Physiol. 151, 113-125. (doi:10.1002/jcp. 1041510116)
75. Verderberg CA. 2008 Integrins step up the pace of cell migration through polyamines and potassium channels. Proc. Natl Acad. Sci. USA 105, 7109-7119. (doi:10.1073/pnas.0803231105)
76. Kessler W, Budde T, Gekle M, Fabian A, Schwab A. 2008 Activation of cell migration with fibroblast growth factor-2 requires calcium-sensitive potassium channels. Pflugers Arch. 456, 813-823. (doi:10.1007/s00424-008-0452-2)
77. Oeggerli M et al. 2012 Role of KCNMA1 in breast cancer. PLoS ONE 7, e41664. (doi:10.1371/journal. pone.0041664)
78. Li M, Xiong ZG. 2001 Ion channels as targets for cancer therapy. Int. J. Physiol. Pathophysiol. Pharmacol. 3, 156-166.
79. Pedersen SF, Stock C. 2013 Ion channels and transporters in cancer: pathophysiology, regulation, and clinical potential. Cancer Res. 73, 1658-1661. (doi:10.1158/0008-5472.CAN-12-4188)
80. Lehen'kyi V, Shapovalov G, Skryma R, Prevarskaya N. 2011 Ion channels and transporters in cancer. 5. Ion channels in control of cancer and cell apoptosis. Am. J. Physiol. Cell Physiol. 301, C1281-1289. (doi:10.1152/ajpcell.00249.2011)
81. Kunzelmann K. 2005 Ion channels and cancer. J. Membr. Biol. 205, 159-173. (doi:10.1007/s00232-005-0781-4)
82. Villalonga N, Ferreres JC, Argilés JM, Condom E, Felipe A. 2007 Potassium channels are a new target field in anticancer drug design. Recent Pat. Anticancer Drug Discov. 2, 212-223. (doi:10.2174/157489207782497181)
83. Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S, Becchetti A. 2009 Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr. Med. Chem. 16, 66-93. (doi:10.2174/092986709787002835)
84. Li M, Xiong ZG. 2011 Ion channels as targets for cancer therapy. Int. J. Physiol. Pathophysiol. Pharmacol. 3, 156-166.
85. + channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch. 448, 274-286. (doi:10.1007/s00424-004-1258-5)
86. Szabò I, Zoratti M, Gulbins E. 2010 Contribution of voltage-gated potassium channels to the regulation of apoptosis. FEBS Lett. 584, 2049-2056. (doi:10.1016/j.febslet.2010.01.038)
87. Pardo LA. 2004 Voltage-gated potassium channels in cell proliferation. Physiology 19, 285-292. (doi:10.1152/physiol.00011.2004)
88. Kaczmarek LK. 2006 Non-conducting functions of voltage-gated ion channels. Nat. Rev. Neurosci. 7, 761-771. (doi:10.1038/nrn1988)
89. Wang LH et al. 2012 Rituzimab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptors. Biochem. Biophys. Acta 1823, 505-513. (doi:10.1016/j.bbamcr.2011.11.012)
90. + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11, 37-51. (doi:10.1016/j.ccr.2006. 10.020)
91. Xie J, Wang BS, Yu DH, Lu Q, Ma J, Qi H, Fang C, Chen HZ. 2011 Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells. Int. J. Oncol. 38, 409-417.
92. Wu J, Zeng T, Wu X, Gao Q, Zhai W, Ding Z. 2013 Ether àgo-go 1 silencing in combination with TRAIL overexpression has synergistic antitumor effects on ostoesarcoma. Cancer Biother. Radiopharm. 28, 65-70. (doi:10.1089/cbr.2012.1283)
93. Asher V, Warren A, Shaw R, Sowter H, Bali A, Khan R. 2011 The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line. Cancer Cell Int. 11, 6. (doi:10.1186/1475-2867-11-6)
94. Hartung F, Stühmer W, Pardo LA. 2011 Tumor cellselective apotosis induction through targeting of Kv10.1 via bifunctional TRAIL antibody. Mol. Cancer 10, 109. (doi:10.1186/1476-4598-10-109)
95. + channels in cell proliferation and apoptosis. Cell Death Dis. 2, e193. (doi:10.1038/cddis.2011.77)
96. 7 receptor pathway. Cell. Physiol. Biochem. 28, 199-208. (doi:10.1159/000331731)
97. Innamaa A et al. 2013 Expression and effects of modulation of the K2P potassium channels TREK01 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer. Clin. Transl. Oncol. 15, 910-918. (doi:10.1007/s12094-013-1022-4)
98. Quast SA, Berger A, Buttstädt N, Friebel K, Schönherr R, Eberle J. 2012 General sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMAC. PLoS ONE 7, e39290. (doi:10.1371/journal.pone.0039290)
99. Ca channels in zoledronic acid-induced apoptosis of MDA-MB-231 brest cancer cells. PLoS ONE 7, e37451. (doi:10.1371/journal.pone.0037451)
100. + channels and endoplasmic reticulum stress. Int. J. Oncol. 41, 465-475.
101. Leanza L, Henry B, Sassi N, Zoratti M, Chandy KG, Gulbins E, Szabò I. 2012 Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells. EMBO Mol. Med. 4, 577-593. (doi:10.1002/emmm.201200235)
102. Zhang R, Tian P, Chi Q, Wang J, Wang Y, Sun L, Liu Y, Tian S, Zhang Q. 2012 Human ether-à-go-gorelated gene expression is essential for cisplatin to induce apoptosis in human gastric cancer. Oncol. Rep. 27, 433-440.
103. + channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation. Hematology 16, 177-184. (doi:10.1179/102453311X12940641878000)
104. McFerrin MB, Turner KL, Cuddapah VA, Sontheimer H. 2012 Differential role of IK and BK potassium channels as mediators of intrinsic and extrinsic apoptotic cell death. Am. J. Physiol. Cell Physiol. 303, C1070-C1078. (doi:10.1152/ajpcell. 00040.2012)
105. + channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention. Curr. Med. Chem. 19, 661-674. (doi:10.2174/092986712798992048)
106. + efflux and apoptosis induced by the potassium channel modulatory protein KCaAP/PIAS3beta in prostate cancer cells. J. Biol. Chem. 277, 17 852-17 862. (doi:10.1074/jbc.M201689200)
107. + channel-mediated tumor cell proliferation and apoptosis. Apoptosis 12, 1837-1846. (doi:10.1007/s10495-007-0101-9)
108. Szabò I, Bock J, Jekle A, Soddemann M, Adams C, Lang F, Zoratti M, Gulbins E. 2005 A novel potassium channel in lymphocyte mitochondria. J. Biol. Chem. 280, 12 790-12 798. (doi:10.1074/jbc.M413548200)
109. Szabò I, Bock J, Grassmé H, Soddemann M, Wilker B, Lang F, Zoratti M, Gulbins E. 2008 Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc. Natl Acad. Sci. USA 105, 14 861-14 866. (doi:10.1073/pnas. 0800915105)
110. Gulbins E, Sassi N, Grassmé H, Zoratti M, Szabò I. 2010 Role of Kv1.3 mitochondrial potassium channel in apoptotic signaling in lymphocytes. Biochim. Biophys. Acta 1797, 1251-1259. (doi:10.1016/j.bbabio.2010.01.018)
111. Leanza L, Zoratti M, Gulbins E, Szabò I. 2012 Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels. Curr. Med. Chem. 19, 5394-5404. (doi:10.2174/092986712 803833281)
112. Duran C, Thompson CH, Xiao Q, Hartzell HC. 2010 Chloride channels; often enigmatic, rarely predictable. Annu. Rev. Physiol. 72, 95-121. (doi:10.1146/annurev-physiol-021909-135811)
113. Okada Y, Maeno E. 2001 Apoptosis, cell volume regulation and volume-regulatory chloride channels. Comp. Biochem. Physiol. 130, 377-383. (doi:10.1016/S1095-6433(01)00424-X)
114. Szabò I, Lepple-Wienhues A, Kaba KN, Zoratti M, Gulbins E, Lang F. 1998 Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes. Proc. Natl Acad. Sci. USA 95, 6169-6174. (doi:10.1073/pnas.95.11.6169)
115. 2 efflux impairment in hematopoietic cell apoptosis. FASEB J. 13, 1711-1723.
116. Elble RC, Pauli BU. 2001 Tumor suppression by a proapoptotic calcium-activated chloride channel in mammary epithelium. J. Biol. Chem. 276, 40 510-40 517. (doi:10.1074/jbc.M104821200)
117. Spitzner M, Martins JR, Soria RB, Ousingsawa J, Scheidt K, Schreiber R, Kunzelmann K. 2008 Eag1 and Bestrophin 1 are up-regulated in fast-growing colonic cancer cells. J. Biol. Chem. 283, 7421-7428. (doi:10.1074/jbc.M703758200)
118. Duvvuri U et al. 2012 TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res. 72, 3270-3281. (doi:10.1158/0008-5472.CAN-12-0475-T)
119. - channel. Proc. Natl Acad. Sci. USA 101, 6770-6773. (doi:10.1073/pnas. 0401604101)
120. Suh KS et al. 2005 Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor α-induced apoptosis, and inhibits tumor growth. Cancer Res. 65, 562-571.